Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II

Bhatnagar, Vibha; Stoto, Michael A.; Morton, Sally C.; Boer, Rob; Bozzette, Samuel A.
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p126
Academic Journal
Background: Because smallpox (variola major) may be used as a biological weapon, we reviewed outbreaks in post-World War II Europe and North America in order to understand smallpox transmission patterns. Methods: A systematic review was used to identify papers from the National Library of Medicine, Embase, Biosis, Cochrane Library, Defense Technical Information Center, WorldCat, and reference lists of included publications. Two authors reviewed selected papers for smallpox outbreaks. Results: 51 relevant outbreaks were identified from 1,389 publications. The median for the effective first generation reproduction rate (initial R) was 2 (range 0-38). The majority outbreaks were small (less than 5 cases) and contained within one generation. Outbreaks with few hospitalized patients had low initial R values (median of 1) and were prolonged if not initially recognized (median of 3 generations); outbreaks with mostly hospitalized patients had higher initial R values (median 12) and were shorter (median of 3 generations). Index cases with an atypical presentation of smallpox were less likely to have been diagnosed with smallpox; outbreaks in which the index case was not correctly diagnosed were larger (median of 27.5 cases) and longer (median of 3 generations) compared to outbreaks in which the index case was correctly diagnosed (median of 3 cases and 1 generation). Conclusion: Patterns of spread during Smallpox outbreaks varied with circumstances, but early detection and implementation of control measures is a most important influence on the magnitude of outbreaks. The majority of outbreaks studied in Europe and North America were controlled within a few generations if detected early.


Related Articles

  • Does smallpox still pose a threat? Weir, Erica // CMAJ: Canadian Medical Association Journal;11/13/2001, Vol. 165 Issue 10, p1380 

    Discusses the public health risk posed by smallpox in light of its possible use as a biological weapon. Epidemiology of smallpox; Symptoms; Prevention of transmission through vaccination and isolation of patients.

  • Smallpox from the grave. Cole, Jack E.; M.O.R. // Cortlandt Forum;10/25/95, Vol. 8 Issue 10, p114 

    Determines whether smallpox virus can be transmitted from an exhumed or dead body. Safety in the assumption that smallpox had been eradicated.

  • A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. Lipsky, Benjamin A.; Moran, Gregory J.; Napolitano, Lena M.; Lien Vo; Nicholson, Susan; Myoung Kim // BMC Infectious Diseases;2012, Vol. 12 Issue 1, p227 

    Background: Complicated skin and soft tissue infections (cSSTIs) occur frequently, but limited data do not allow any consensus on an optimal treatment strategy. We designed this prospective, multicenter, observational study to explore the current epidemiology, treatment, and resulting clinical...

  • Vaccinia Virus Infections in Martial Arts Gym, Maryland, USA, 2008. Hughes, Christine M.; Blythe, David; Yu Li; Reddy, Ramani; Jordan, Carol; Edwards, Cindy; Adams, Celia; Conners, Holly; Rasa, Catherine; Wilby, Sue; Russell, Jamaal; Russo, Kelly S.; Somsel, Patricia; Wiedbrauk, Danny L.; Dougherty, Cindy; Allen, Christopher; Frace, Mike; Emerson, Ginny; Olson, Victoria A.; Smith, Scott K. // Emerging Infectious Diseases;Apr2011, Vol. 17 Issue 4, p730 

    Vaccinia virus is an orthopoxvirus used in the live vaccine against smallpox. Vaccinia virus infections can be transmissible and can cause severe complications in those with weakened immune systems. We report on a cluster of 4 cases of vaccinia virus infection in Maryland, USA, likely acquired...

  • FDA Approves Drug for Adverse Reactions to Smallpox Vaccine.  // Clinical Infectious Diseases;7/1/2005, Vol. 41 Issue 1, preceding p1 

    The article reports on the U.S. FDA's approval for the drug vaccinia immune globulin developed by Cangene Corp. The drug is used to treat and prevent certain adverse reactions to the smallpox vaccine. FDA approval comes 9 months after Winnipeg, Manitoba-based Cangene submitted its application....

  • The Demon in the Freezer. Preston, Richard // New Yorker;07/12/99, Vol. 75 Issue 18, p44 

    Presents information on how smallpox became a bioterrorist threat to the human species. Details on the history of smallpox; Types of smallpox; Discussion on smallpox immunity; Availability of smallpox vaccine; Use of the virus in the military; Actions taken by the World Health Organization.

  • Will Smallpox Be the Next Bioweapon?  // Current Science;2/8/2002, Vol. 87 Issue 12, p7 

    Focuses on the ancient disease named smallpox, which spreads from person to person, through coughing and sneezing. Possibility of smallpox to become a biological weapon; Plans of health officials to begin routine smallpox vaccination; Storage of 15 million doses of smallpox vaccine.

  • Smallpox Vaccine Policy: The National Debate. Benjamin, Georges C. // Physician Executive;Sep/Oct2002, Vol. 28 Issue 5, p64 

    Discusses the concern of the U.S. about the use of smallpox as a biological weapon and the need to reinstitute a national smallpox vaccination program. Historical background of the disease; Increase in the concern after the 2001 anthrax attacks; Feasibility in vaccination of the entire...

  • The Threat of Smallpox.  // Junior Scholastic;11/29/2002, Vol. 105 Issue 8, p3 

    Focuses on the Smallpox disease. Eradication of smallpox; Threat of using laboratory samples of smallpox to develop biological weapons by terrorists; Need for immunization of doctors and nurses in hospitals against smallpox.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics